Contract facts
Federal8511496925!SEAT,VALVE is a federal award for Dla Aviation held by Northrop Grumman Systems Corp. Estimated value $1.3M ($1.3M obligated). Current period of performance ends Mar 1, 2027. Place of performance: SUNNYVALE CA.
Recompete timing
PublicCurrent PoP ends Mar 1, 2027 (192 days remaining). Agencies typically plan 12–18 months ahead — at 6.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordNorthrop Grumman Systems Corp — $792.9M obligated across 1,121 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract SPE4AX25F5829?
SPE4AX25F5829 (8511496925!seat VALVE) is a Dla Aviation award with a potential value of $1.3M, currently held by Northrop Grumman Systems Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is SPE4AX-25-F-5829?
SPE4AX-25-F-5829 is the dashed form of PIID SPE4AX25F5829 (8511496925!seat VALVE), held by Northrop Grumman Systems Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded SPE4AX25F5829?
Dla Aviation awarded SPE4AX25F5829 to Northrop Grumman Systems Corp (potential $1.3M).
Who is the incumbent on SPE4AX25F5829?
Northrop Grumman Systems Corp is the incumbent with $792.9M across 1121 related awards in SCOUT’s public footprint. The current period of performance ends Mar 1, 2027.
When does Northrop Grumman Systems Corp’s SPE4AX25F5829 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 1, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.